Meeder Advisory Services »

Iovance Biotherapeutics shares owned by Meeder Advisory Services

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Meeder Advisory Services from 13F filings

Historical chart of Meeder Advisory Services investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Meeder Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Meeder Advisory Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 15k 2.17
2025-06-30 $47k 27k 1.72
2025-03-31 $51k 15k 3.33

More positions owned by Meeder Advisory Services

J P Morgan Exchange Traded F Municipal Etf (JMUB)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
New York Life Invts Active E Nyli Mackay Mun (MMIT)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Franklin Templeton Etf Tr Franklin Dyn Mun (FLMI)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Victory Portfolios Ii Core Intermediat (UITB)

View all positions for Meeder Advisory Services

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics